PUOTI MASSIMO

Travi, G., Peracchi, F., Merli, M., Ravano, E., Frustaci, A., Deodato, M., et al. (2025). Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection. INFECTIOUS DISEASE REPORTS, 17(2) [10.3390/idr17020017]. Detail

Monti, B., Rossotti, R., D'Aloia, F., Calzavara, D., Corsico, L., Cernuschi, M., et al. (2025). Challenges and opportunities for hepatitis B virus screening in people attending PrEP services: a retrospective prevalence study. SEXUALLY TRANSMITTED INFECTIONS, 101(2), 121-124 [10.1136/sextrans-2024-056245]. Detail

Piselli, P., Tavelli, A., Cimaglia, C., Muccini, C., Bandera, A., Marchetti, G., et al. (2025). Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data. INTERNATIONAL JOURNAL OF CANCER, 157(6), 1142-1153 [10.1002/ijc.35493]. Detail

Mussini, C., Giacomelli, A., Quiros-Roldan, E., Mazzotta, V., Di Biagio, A., De Vito, A., et al. (2025). Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation. ECLINICALMEDICINE, 86(August 2025) [10.1016/j.eclinm.2025.103368]. Detail

Moschese, D., Raccagni, A., Giacomelli, A., Piralla, A., Rossotti, R., Raimondi, A., et al. (2025). Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024. CLINICAL INFECTIOUS DISEASES, 80(1 (15 January 2025)), 234-236 [10.1093/cid/ciae184]. Detail